Literature DB >> 15284456

Argonaute2 is the catalytic engine of mammalian RNAi.

Jidong Liu1, Michelle A Carmell, Fabiola V Rivas, Carolyn G Marsden, J Michael Thomson, Ji-Joon Song, Scott M Hammond, Leemor Joshua-Tor, Gregory J Hannon.   

Abstract

Gene silencing through RNA interference (RNAi) is carried out by RISC, the RNA-induced silencing complex. RISC contains two signature components, small interfering RNAs (siRNAs) and Argonaute family proteins. Here, we show that the multiple Argonaute proteins present in mammals are both biologically and biochemically distinct, with a single mammalian family member, Argonaute2, being responsible for messenger RNA cleavage activity. This protein is essential for mouse development, and cells lacking Argonaute2 are unable to mount an experimental response to siRNAs. Mutations within a cryptic ribonuclease H domain within Argonaute2, as identified by comparison with the structure of an archeal Argonaute protein, inactivate RISC. Thus, our evidence supports a model in which Argonaute contributes "Slicer" activity to RISC, providing the catalytic engine for RNAi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284456     DOI: 10.1126/science.1102513

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1077 in total

1.  EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma.

Authors:  Steven S Chang; Ian Smith; Chad Glazer; Patrick Hennessey; Joseph A Califano
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2010-10-01       Impact factor: 1.538

2.  An antiviral RISC isolated from Tobacco rattle virus-infected plants.

Authors:  Jessica J Ciomperlik; Rustem T Omarov; Herman B Scholthof
Journal:  Virology       Date:  2011-01-26       Impact factor: 3.616

Review 3.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

4.  Argonaute-bound small RNAs from promoter-proximal RNA polymerase II.

Authors:  Jesse R Zamudio; Timothy J Kelly; Phillip A Sharp
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

Review 5.  The use of nanoparticulates to treat breast cancer.

Authors:  Xiaomeng Tang; Welley S Loc; Cheng Dong; Gail L Matters; Peter J Butler; Mark Kester; Craig Meyers; Yixing Jiang; James H Adair
Journal:  Nanomedicine (Lond)       Date:  2017-09-04       Impact factor: 5.307

6.  A Neuronal piRNA Pathway Inhibits Axon Regeneration in C. elegans.

Authors:  Kyung Won Kim; Ngang Heok Tang; Matthew G Andrusiak; Zilu Wu; Andrew D Chisholm; Yishi Jin
Journal:  Neuron       Date:  2018-01-27       Impact factor: 17.173

7.  Tudor nuclease genes and programmed DNA rearrangements in Tetrahymena thermophila.

Authors:  Rachel A Howard-Till; Meng-Chao Yao
Journal:  Eukaryot Cell       Date:  2007-08-22

Review 8.  The rise of regulatory RNA.

Authors:  Kevin V Morris; John S Mattick
Journal:  Nat Rev Genet       Date:  2014-04-29       Impact factor: 53.242

9.  Genome-wide analysis of mRNAs regulated by Drosha and Argonaute proteins in Drosophila melanogaster.

Authors:  Jan Rehwinkel; Pavel Natalin; Alexander Stark; Julius Brennecke; Stephen M Cohen; Elisa Izaurralde
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Genome-wide analysis of mir-548 gene family reveals evolutionary and functional implications.

Authors:  Tingming Liang; Li Guo; Chang Liu
Journal:  J Biomed Biotechnol       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.